MRFF 2024 Rapid Applied Research Translation

Overview

The 2024 Rapid Applied Research Translation Grant Opportunity is part of the Medical Research Future Fund and the Rapid Applied Research Translation Initiative. This initiative supports the translation of research evidence into clinical practice and better quality of care for patients by encouraging collaborations between academic researchers, health service providers, consumers and other end users on projects to improve health care delivery, service and systems sustainability. Consistent with the Medical Research Future Fund Act 2015, the objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that: deliver late stage translational research that is directly relevant to clinical care, health services and/or health practices, which has the potential to be translated into existing policy and practice use existing knowledge and evidence to support and accelerate the translation of research findings into improved health care and health interventions address a clearly defined gap in best practice health care and health interventions to improve health outcomes, as identified by collaborating health services involve all stakeholders relevant to the research and its translation in its conceptualisation, design and implementation, including health care consumers and providers. Two streams of funding are available: Stream 1 (Accelerator): the Chief Investigators are primarily resident in any area according to the Modified Monash Model (MM1-7) Stream 2 (Accelerator): the Chief Investigator A and 50% or more of all Chief Investigators are primarily resident in a regional, rural, or remote area according to the Modified Monash Model (MM2-7). For this grant opportunity, an application may be submitted to one of the above two Streams only. Applicants must specify the Stream they are applying for in their application.